Group items tagged

"India Pharmaceuticals & Healthcare Report" provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Indian pharmaceutical and healthcare industry.

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka ...

At AmbitPCDPharma, a leading PCD Pharma Company providing PCD Franchise in Gujarat, distributor all over India. Our companies offer pharmaceutical products which are widely appreciated for its accurate composition, effectiveness and purity in India.

We are one of the leading Molnova capsule manufacturer, supplier and exporter in India. Molnova Capsule is Very effective for the treatment of the COVID-19 virus.It is the brand name of Molnupiravir.Known as one of the leading research-based Pharmaceutical manufacturers and exporters globally.We are serving our customers for more than 10 years.

The drug controller issued emergency use authorization to pharmaceutical businesses in India to produce generic versions of molnupiravir.

This division of Ind Swift aspires to help those who cannot afford costly branded medicines. It is further divided into Agile, Maxcare and Health Care divisions which include a vast array of over 500 products from various therapeutic segments namely Antibiotic, Anti-Infectives, Anti-Cold, Nutraceuticals, Anti-Convulsants, Analgesics, Anti-Diarrhoeal, Anti-Allergics, Anti-Inflammatory and Anti-Ulcer Drugs, Hypolipidaemic Drugs, Anti Malarial, Enzyme, Expectorants, Antipsychotics & Anti-Depressants.

Contract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a single step. Contract manufacturers usually produce vaccines at their facilities; however, some contract manufacturers also service the field through the provision of workspace and by taking care of the closing storage and final disposition of finished products. Some contract manufacturers specialize in the manufacture of one or few vaccines. Others manufacture vaccines for a number of diseases. Technological developments in biomanufacturing and biotechnology are expected to drive growth of the global vaccine contract manufacturing market. Biotechnology has witnessed significant growth in the recent past in both developed and emerging economies. According to the India Brand Equity Foundation (IBEF), the Indian biotechnology industry was valued at US$ 63 billion in 2019 and is expected to reach US$ 102 billion by 2025, registering a CAGR of 10.9%. Besides, key biotechnology and pharmaceutical companies are focused on launching vaccines for protection against infectious diseases. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/vaccine-contract-manufacturing-market.html